| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/18/2007 | CA2418267C Method of screening ptp zeta activity promoter or inhibitor |
| 09/18/2007 | CA2415494C Method of detection by enhancement of silver staining |
| 09/18/2007 | CA2377071C Methods and apparatus for performing array microcrystallizations |
| 09/18/2007 | CA2337197C Microdevices for screening biomolecules |
| 09/18/2007 | CA2333299C Method and apparatus for magnetically separating selected particles, particularly biological cells |
| 09/18/2007 | CA2299586C Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2253850C Method and apparatus for automatically detecting malignancy-associated changes |
| 09/18/2007 | CA2177143C Metal chelate containing compositions for use in chemiluminescent assays |
| 09/16/2007 | CA2581960A1 Iap bir domain binding compounds |
| 09/16/2007 | CA2539902A1 Method of enhancing degradation of chitin |
| 09/15/2007 | CA2579507A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/15/2007 | CA2545597A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/15/2007 | CA2540223A1 Drug reaction early warning system |
| 09/13/2007 | WO2007104062A2 Compositions and methods based on peptide binding profiling |
| 09/13/2007 | WO2007103969A2 Fluidic system for a flow cytometer |
| 09/13/2007 | WO2007103946A2 Module for automated matrix removal in acidic plating solutions |
| 09/13/2007 | WO2007103802A2 Nanorice particles: hybrid plasmonic nanostructures |
| 09/13/2007 | WO2007103792A2 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 09/13/2007 | WO2007103788A2 Yeast reporter system based on fusion proteins of sup35p |
| 09/13/2007 | WO2007103747A1 Assessing non-alcoholic fatty liver disease |
| 09/13/2007 | WO2007103734A2 Method for quantifying an analyte in a biological sample using mass spectrometry |
| 09/13/2007 | WO2007103614A2 Method of quantitatively measuring trace amounts of metals in polymer samples |
| 09/13/2007 | WO2007103568A2 Methods and compositions for the diagnosis of diseases of the aorta |
| 09/13/2007 | WO2007103541A2 Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
| 09/13/2007 | WO2007103538A2 Methods of multiple antibody labeling and uses thereof |
| 09/13/2007 | WO2007103474A2 Drug adherence monitoring system |
| 09/13/2007 | WO2007103406A2 Cellular predictive models for toxicities |
| 09/13/2007 | WO2007103146A2 Truncated proteins as cancer markers |
| 09/13/2007 | WO2007103124A2 Methods for distinguishing isomers using mass spectrometry |
| 09/13/2007 | WO2007103112A2 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/13/2007 | WO2007102869A2 Treatment of ovarian cancer with clostridium perfringens enterotoxin |
| 09/13/2007 | WO2007102787A1 Human embryonic stem cell methods and podxl expression |
| 09/13/2007 | WO2007102629A1 Carbon nanotube transistor biosensors with aptamers as molecular recognition elements and method for sensing a target material using the same |
| 09/13/2007 | WO2007102526A1 Methods for diagnosing pancreatic cancer using reg4 protein |
| 09/13/2007 | WO2007102442A1 Monoclonal antibody, hybridoma, and method for quantification of lipopolysaccharide |
| 09/13/2007 | WO2007102410A1 Novel use of rage polypeptide |
| 09/13/2007 | WO2007102396A1 Method for production of labeled sphingolipid |
| 09/13/2007 | WO2007102277A1 Optical waveguide mode sensor |
| 09/13/2007 | WO2007102240A1 Oasis gene-deficient mouse |
| 09/13/2007 | WO2007102018A1 Markers for atherosclerosis |
| 09/13/2007 | WO2007101993A2 Electromagnetic assay |
| 09/13/2007 | WO2007101991A1 Target for the enhancement qf cognitive function |
| 09/13/2007 | WO2007101960A2 Device and method for identifying a fuel |
| 09/13/2007 | WO2007101913A1 Novel assay for the detection of an antibody bound to a cell membrane receptor |
| 09/13/2007 | WO2007101795A2 Method and device for testing the quality of a metallic coating |
| 09/13/2007 | WO2007101710A1 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| 09/13/2007 | WO2007101662A2 Safety approach for diagnostic systems |
| 09/13/2007 | WO2007101661A1 Anti-drug antibody assay |
| 09/13/2007 | WO2007101653A1 Method of carrying out a reaction for replicating a nucleic acid |
| 09/13/2007 | WO2007101631A1 Test for the detection of pathological prions |
| 09/13/2007 | WO2007101347A1 Bir domain binding compounds |
| 09/13/2007 | WO2007101341A1 Xaf-1, a diagnostic marker for interferon responsiveness in multiple sclerosis |
| 09/13/2007 | WO2007101306A1 Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same |
| 09/13/2007 | WO2007086997A3 Sensors |
| 09/13/2007 | WO2007082138A3 Antibody-dependent cellular cytotoxicity assay |
| 09/13/2007 | WO2007081778A3 Multiplexed detection of anti-red cell alloantibodies |
| 09/13/2007 | WO2007079149A3 Blood cell sorting methods and systems |
| 09/13/2007 | WO2007076445A3 System and device for detecting markers associated with a urinary tract infection |
| 09/13/2007 | WO2007076240A3 Compositions and methods for lipoprotein uptake assays |
| 09/13/2007 | WO2007076017A3 Electrochemical sensor system using a substrate with at least one aperature and method of making the same |
| 09/13/2007 | WO2007076013A3 Homocysteine immunoassay |
| 09/13/2007 | WO2007075687A3 Methods for assessing the pro-inflammatory immune health of an individual |
| 09/13/2007 | WO2007075601A3 Methods for assessing the pro-inflammatory immune health of an individual |
| 09/13/2007 | WO2007073899A8 Diagnostic test for inflammatory endothelial dysfunctions in pregnancies |
| 09/13/2007 | WO2007073706A3 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 09/13/2007 | WO2007067991A3 Human monoclonal antibodies to o8e |
| 09/13/2007 | WO2007067900A3 Biomarkers for amyotrophic lateral sclerosis |
| 09/13/2007 | WO2007064813A3 Apparatus and method for portable blood cell counting |
| 09/13/2007 | WO2007064355A9 Carbon nanotube-based glucose sensor |
| 09/13/2007 | WO2007059143A3 Methods of identifying and treating individuals exhibiting mdr-1 overexpression with protein tyrosine kinase inhibitors and combinations thereof |
| 09/13/2007 | WO2007059065B1 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia |
| 09/13/2007 | WO2007057750A3 Assays |
| 09/13/2007 | WO2007055294A3 Method for determination of substances simultaneously, and support for use in the method |
| 09/13/2007 | WO2007054800A3 High pressure optical cell for a downhole optical fluid analyzer |
| 09/13/2007 | WO2007050052A3 Process for treatment of protein samples |
| 09/13/2007 | WO2007046044A3 Vial for test strips |
| 09/13/2007 | WO2007044607A8 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 09/13/2007 | WO2007042309A3 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 09/13/2007 | WO2007041438A3 Compositions comprising glycerophosphodiester phosphodiesterase (gde) and uses thereof |
| 09/13/2007 | WO2007026972A3 Binding protein molecule |
| 09/13/2007 | WO2007022089A3 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products |
| 09/13/2007 | WO2007005222A3 Cyanine dyes and methods of use in biological applications |
| 09/13/2007 | WO2006138418A3 Improvement of cognitive performance with sirtuin activators |
| 09/13/2007 | WO2006135677A3 Zebrafish assay |
| 09/13/2007 | WO2006074350A3 Systems and methods for rapidly changing the solution environment around sensors |
| 09/13/2007 | WO2006052991A3 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 09/13/2007 | WO2005119560A3 Clinical data management system |
| 09/13/2007 | WO2005118834A3 Methods for identifying risk of breast cancer and treatment thereof |
| 09/13/2007 | WO2005115354A3 Compositions and methods for bone formation and remodeling |
| 09/13/2007 | WO2005062780A3 In vivo odorant receptor systems and their uses |
| 09/13/2007 | WO2005040347A3 Methods and compositions for inhibiting cell growth and proliferation |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | WO2000061614A8 Uncoupling proteins |
| 09/13/2007 | US20070214509 Methods and systems for identifying compounds that modulate alpha-synuclein aggregation |
| 09/13/2007 | US20070213961 System and Methods for Optimized Drug Delivery and Progression of Diseased and Normal Cells |
| 09/13/2007 | US20070213608 Method and apparatus for remote health monitoring and providing health related information |
| 09/13/2007 | US20070213605 Blood glucose monitoring system |
| 09/13/2007 | US20070213604 Blood glucose monitoring system |
| 09/13/2007 | US20070213603 Blood glucose monitoring system |